Bioactive N-terminal undecapeptides derived from parathyroid hormone: The role of α-helicity

Journal of Peptide Research

Volumn 65, Issue 1, 2005, Pages 23-35

  Barazza, A ^a   Wittelsberger, A ^a   Fiori, N ^b   Schievano, E ^b   Mammi, S ^b   Toniolo, C ^b   Alexander, J M ^a   Rosenblatt, M ^a   Peggion, E ^b   Chorev, M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

helix; C tetrasubstituted amino acids; Nuclear magnetic resonance; Parathyroid hormone (PTH)

Indexed keywords

1 AMINOCYCLOHEXANECARBOXYLIC ACID; AMINO ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CYCLIC AMP; CYCLOHEXANE DERIVATIVE; CYCLOLEUCINE; ISOBUTYRIC ACID DERIVATIVE; LIGAND; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE[1-11]; PARATHYROID HORMONE[1-14]; PARATHYROID HORMONE[1-34]; PEPTIDE DERIVATIVE; TRIFLUOROETHANOL; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGICAL ACTIVITY; CIRCULAR DICHROISM; COMPUTER SIMULATION; DRUG CONFORMATION; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOLECULAR STABILITY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; CELL LINE; CIRCULAR DICHROISM; CYCLIC AMP; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; OLIGOPEPTIDES; PARATHYROID HORMONE; PROTEIN STRUCTURE, SECONDARY; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTORS, PARATHYROID HORMONE;

EID: 20044384535     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2005.00207.x     Document Type: Article

References (57)

1. Chorev, M., Alexander, J. & Rosenblatt, M. (2001) Interactions of parathyroid hormone and parathyroid hormone-related protein with their receptors. In: The Parathyroids - Basic and Clinical Concepts (Bilezikian, J., Levine, M. & Marcus, R., eds), pp. 53-91. Raven Press, New York.
2. Chorev, M. & Rosenblatt, M. (2002) Parathyroid hormone-receptor interactions. In: Principles of Bone Biology (Bilezikian, J., Raisz, L. & Rodan, G.A., eds), pp. 423-461. Academic Press, San Diego, USA.
3. Neer, R.M., Arnaud, C.D., Zanchetta, S.R., Prince, R., Gaich, G.A., Reginster, S.Y., Hodsman, A.B., Eriksen, E.F., Ish-Shalom, S., Genant, H.U., Wang, O., Mitlak, B.H., Mellstrom, D., Oefjord, E.S., Marcinowska-Sucho Wiersjka, E., Salmi, S., Mulder, H., Halse, J. & Sawicki, A.Z. (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl J. Med. 344, 1434-1441.
4. Marx, U.C., Austermann, S., Bayer, P., Adermann, K., Eschart, A., Stich, H., Walter, S., Schmid, F.X., Janicke, R., Forssmann, W.G. & Rosch, P. (1995) Structure of human parathyroid hormone 1-37 in solution. J. Biol. Chem. 270, 15194-15202.
5. 2-terminal human parathyroid hormone fragments. J. Biol. Chem. 273, 4308-4316.
6. Marx, U.C., Adermann, K., Bayer, P., Forssmann, W.G. & Rosch, P. (2000) Solution structures of human parathyroid hormone fragments hPTH(1-34) and hPTH(1-39) and bovine parathyroid hormone fragment hPTH(1-31). Biochem. Biophys. Res. Commun. 267, 213-220.
7. Pellegrini, M., Bisello, A., Rosenblatt, M., Chorev, M. & Mierke, D.F. (1998) Binding domain of human parathyroid hormone receptor: from conformation to function. Biochemistry 37, 12737-12743.
8. Pellegrini, M., Royo, M., Rosenblatt, M., Chorev, M. & Mierke, D.F. (1998) Addressing the tertiary structure of human parathyroid hormone-(1-34). J. Biol. Chem. 273, 10420-10427
9. Schievano, E., Mammi, S., Silvestri, L., Behar, V., Rosenblatt, M., Chorev, M. & Peggion, E. (2000) Conformational studies of parathyroid hormone (PTH)/PTH-related protein (PTHrp) chimeric peptides. Biopolymers 54, 429-447.
10. Wray, V., Federau, T., Gronwald, W., Mayer, H., Schomburg, D., Tegge, W. & Wingender, E. (1994) The structure of human parathyroid hormone from a study of fragments in solution using 1H NMR spectroscopy and its biological implications. Biochemistry 33, 1684-1693.
11. 1H NMR spectroscopy of the structural behaviour of human parathyroid-hormone-related protein(1-34) and its close relationship with the N-terminal fragments of human parathyroid hormone in solution. Biol. Chem. Hoppe-Seyler 378, 1501-1508, and references therein.
12. Barden, J.A. & Kemp, B.E. (1996) Evidence that the PTH receptor binding site on PTHrP(1-34) can hinge at Arg19/Arg20. Biochem. Biophys. Res. Commun. 220, 431-436.
13. Ray, F.R., Barden, J.A. & Kemp, B.E. (1993) NMR solution structure of the [Ala26]parathyroid-hormone-related protein(1-34) expressed in humoral hypercalcemia of malignancy. Eur. J. Biochem. 211, 205-211.
14. Barden, J.A. & Kemp, B.E. (1989) NMR study of a 34-residue N-terminal fragment of the parathyroid-hormone-related protein secreted during humoral hypercalcemia of malignancy. Eur. J. Biochem. 184, 379-394.
15. Barden, J.A. & Kemp, B.E. (1993) NMR solution structure of human parathyroid hormone(1-34). Biochemistry 32, 7126-7132.
16. Chen, Z., Xu, P., Barbier, J.R., Willick, G. & Ni, F. (2000) Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone. Biochemistry 39, 12766-12777.
17. Bundi, A., Andreatta, R., Rittel, W. & Wüthrich, K. (1976) Conformational studies of the synthetic fragment 1-34 of human parathyroid hormone by NMR techniques. FEBS Lett. 64, 126-129.
18. 1H nuclear magnetic resonance techniques. Eur. J. Biochem. 91, 201-208.
19. Smith, L.M., Jentoft, J. & Zull, J.E. (1987) Proton NMR studies of the biologically active 1-34 fragment of bovine parathyroid hormone: examination of a structural model. Arch. Biochem. Biophys. 253, 81-86.
20. Lee, S.C. & Russell, A.F. (1989) Two-dimensional 1H-NMR study of the 1-34 fragment of human parathyroid hormone. Biopolymers 28, 1115-1127.
21. Klaus, W., Dieckmann, T., Wray, V., Schomburg, D., Wingender, E. & Mayer, H. (1991) Investigation of the solution structure of the human parathyroid hormone fragment (1-34) by proton NMR spectroscopy, distance geometry, and molecular dynamics calculations. Biochemistry 30, 6936-6942.
22. Strickland, L.A., Bozzato, R.P. & Kronis, K.A. (1993) Structure of human parathyroid hormone(1-34) in the presence of solvents and micelles. Biochemistry 32, 6050-6057.
23. Neugebauer, W., Barbier, J.R., Sung, W.L., Whitfield, J.F. & Willick, G.E. (1995) Solution structure and adenylyl cyclase stimulating activities of C-terminal truncated human parathyroid hormone analogues. Biochemistry 34, 8835-8842.
24. Kanaori, K., Takai, M. & Nosaka, A.Y. (1997) Comparative study of chicken and human parathyroid hormone-(1-34)-peptides in solution with SDS. Eur. J. Biochem. 249, 878-885.
25. Weidler, M., Marx, U.C., Seidel, G., Schafer, W., Hoffmann, E., Ebwein, A. & Rosch, P. (1999) The structure of human parathyroid hormone-related protein(1-34) in near-physiological solution. FEBS Lett. 444, 239-244.
26. Jin, L., Briggs, S.L., Chandrasekar, S., Chirgadze, N.Y., Clavson, D. K., Schevitz, R.W., Smiley, D.L., Tashjian, A.A. & Zhang, F. (2000) Crystal structure of human parathyroid hormone 1-34 at 0.9-Å resolution. J. Biol. Chem. 175, 27238-27244.
27. Wittelsberger, A., Corich, M., Lee, B.K., Barazza, A., Mierke, D.F., Alexander, J.M., Rosenblatt, M. & Chorev, M. (2004) Interactions of the mid-region of parathyroid hormone (1-34) with the receptor orient the hormone for receptor activation. In: Peptide Revolution: Genomics, Proteomics and Therapeutics. Proceedings of the 18th American Peptide Symposium (Chorev, M. & Sawyer, T., eds), pp. 679-681. American Peptide Society, San Diego, USA.
28. Shimizu, M., Potts, J.T. Jr & Gardella, T.J. (2000) Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J. Biol. Chem. 275, 21836-21843.
29. Shimizu, M., Carter, P.H., Khatri, A., Potts, J.T. Jr & Gardella, T.J. (2001) Enhanced activity in parathyroid hormone-(1-14) and - (1-11): novel peptides for probing ligand-receptor interactions. Endocrinology 142, 3068-3074.
30. Shimizu, N., Guo, J. & Gardella, T.J. (2001) Parathyroid hormone (PTH)-(1-14) and - (1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J. Biol. Chem. 276, 49003-49012.
31. Kaul, R. & Balaram, P. (1999) Stereochemical control of peptide folding. Bioorg. Med. Chem. 7, 105-117.
32. 10-helix. Trends Biochem. Sci. 16, 350-353.
33. Toniolo, C., Crisma, M., Formaggio, F. & Peggion, C. (2001) Control of peptide conformation by the Thorpe-Ingold effect (Cα-tetrasubstitution) . Biopolymers (Pept. Sci.) 60, 396-419.
34. Karle, I.L. & Balaram, P. (1990) Structural characteristics of alpha-helical peptide molecules containing Aib residues. Biochemistry 29, 6747-6756.
35. Bardi, R., Piazzesi, A., Toniolo, C., Sukumar, M. & Balaram, P. (1986) Stereochemistry of peptides containing 1-aminocyclopentanecarboxylic acid (Acc5): solution and solid-state conformations of Boc-Acc5-Acc5-NHMe. Biopolymers 25, 1635-1644.
36. α,α dialkylated glycines: a conformational energy calculation and X-ray diffraction study of homopeptides from 1-aminocyclopentane-1-carboxylic acid. Int. J. Biol. Macromol. 10, 292-299.
37. Paul, P.K.C., Sukumor, M., Bardi, R., Piazzesi, A.M., Valle, G., Toniolo, C. & Balaram, P. (1986) Stereochemically constrained peptides. Theoretical and experimental studies on the conformations of peptides containing 1-aminocyclohexanecarboxylic acid. J. Am. Chem. Soc. 108, 6363-6370.
38. Valle, G., Crisma, M., Toniolo, C., Sen, N., Sukumar, N. & Balaram, P. (1988) Crystallographic characterization of conformation of the 1-aminoacyl-hexane-1-carboxylic acid in simple derivative and peptides. J. Chem. Soc., Perkins Trans. II, 393-398.
39. Pavone, V., Benedetti, E., Di Blasio, B., Lelj, F., Pedone, C., Santini, A., Crisma, M., Bonora, G.M. & Toniolo, C. (1988) Structural versatility of peptides from Cαα-dialkylated glycines. A conformational energy computation and X-ray diffraction study of homopeptides from 1-aminocyclohexane-1-carboxylic acid. Macromolecules 21, 2064-2070.
40. Merrifield, R.B. (1963) Solid phase peptide synthesis: I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85, 2149-2154.
41. Kaiser, E., Colescott, R.L., Bossinger, C.D. & Cook, P.I. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595-598.
42. Carpino, L., El-Faham, A., Minor, C. & Albericio, F. (1994) Advantageous applications of azabenzotriazole (triazolopyridine)-based coupling reagents to solid-phase peptide synthesis. J. Chem. Soc., Chem. Commun. 2, 203-210.
43. Gisin, B.F. (1972) The monitoring of reactions in solid-phase peptide synthesis with picric acid. Anal. Chim. Acta 58, 248-249.
44. Arad, O. & Houghten, R.A. (1990) An evaluation of the advantages and effectiveness of picric acid monitoring during solid phase peptide synthesis. Pept. Res. 3, 42-50.
45. Pines, M., Adams, A.E., Stueckle, S., Bessalle, R., Rashti-Behar, V., Chorev, M., Rosenblatt, M. & Suva, L.S. (1994) Generation and characterization of human kidney cell lines stably expressing recombinant human PTH/PTHrP receptor: lack of interaction with a C-terminal human PTH peptide. Endocrinology 135,1713-1716.
46. Greenfield, N. & Fasman, G.D. (1969) Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8, 4108-4116.
47. Ranee, M., Sørensen, O.W., Bodenhausen, G., Wagner, G., Ernst, R.R. & Wüthrich, K. (1983) Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117, 479-485.
48. Bax, A. & Davis, D. (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
49. Griesinger, C., Otting, G., Wüthrich, K. & Ernst, R. (1988) Clean TOCSY for proton spin system identification in macromolecules. J. Am. Chem. Soc. 110, 7870-7872.
50. Bull, T. (1988) ROESY relaxation theory. J. Magn. Reson. 80, 470-481.
51. Nakamoto, C., Behar, V., Chin, K.R., Adams, A.E., Suva, L.S., Rosenblatt, M. & Chorev, M. (1995) Probing the bimolecular interactions of parathyroid hormone the human parathyroid hormone/parathyroid hormone-related protein receptor. 1. Design synthesis and characterization of photoreactive benzophenone-containing analogs of parathyroid hormone. Biochemistry 34, 10546-10552.
52. Shimizu, N., Petroni, B.D., Khatri, A. & Gardella, T.J. (2003) Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues. Biochemistry 42, 2282-2290.
53. Tsomaia, N., Pellegrini, M., Hyde, K., Gardella, T.J. & Mierke, D.F. (2004) Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues. Biochemistry 43, 690-699.
54. Pastore, A. & Saudek, V. (1990) The relationship between chemical shift and secondary structure in proteins. J. Magn. Reson. 90, 165-176.
55. Barazza, A., Fiori, N., Schievano, E., Mammi, S., Alexander, J.M., Rosenblatt, M. & Chorev, M. (2004) Bioactive N-terminal undecapeptides derived from parathyroid hormone. The Role of α-Helicity. In: Peptide Revolution: Genomics, Proteomics and Therapeutics. Proceedings of the 18th American Peptide Symposium (Chorev, M. & Sawyer, T., eds), pp. 673-674. American Peptide Society, San Diego, USA.
56. Lee, E.J., Kim, H.Y., Cho, M.K., Lee, W. & Lim, S.K. (2004) Structure and function of a minimal receptor activation domain of parathyroid hormone. Yonsei Med. J. 45, 419-427.
57. Lim, S.K., Lee, E.J., Kim, H.Y. & Lee, W. (2004) The 10th and 11th residues of short length N-terminal PTH(1-12) analogue are important for its optimum potency. J. Pept. Res. 64, 25-32.